{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:11:57Z","timestamp":1788405117069,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,2]],"date-time":"2027-09-02T00:00:00Z","timestamp":1819843200000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007915","name":"BAYLOR COLLEGE OF MEDICINE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011517","name":"Lucille P Markey Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011517","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015581","name":"Houston Methodist Academic Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.06.020","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:14:17Z","timestamp":1781136857000},"page":"5145-5156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting emerging respiratory pathogens with clamp peptides: Broad-spectrum inhibition of viral entry in 3D human lung models"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2972-5377","authenticated-orcid":false,"given":"Mercedes","family":"Lozano-Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep-Ramon","family":"Codina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Mascini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Dikici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna K.","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3753-6074","authenticated-orcid":false,"given":"Joan E.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9182-216X","authenticated-orcid":false,"given":"Sasha R.","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Daunert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.06.020_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0042098020910873","article-title":"Extended urbanisation and the spatialities of infectious disease: Demographic change, infrastructure and governance","volume":"58","author":"Connolly","year":"2020","journal-title":"Urban Stud."},{"key":"10.1016\/j.ymthe.2026.06.020_bib2","doi-asserted-by":"crossref","first-page":"22336","DOI":"10.1007\/s11356-020-08896-w","article-title":"Climatic changes and their role in emergence and re-emergence of diseases","volume":"27","author":"El-Sayed","year":"2020","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.ymthe.2026.06.020_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","article-title":"Infectious disease in an era of global change","volume":"20","author":"Baker","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ymthe.2026.06.020_bib4","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41591-021-01381-y","article-title":"Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries","volume":"27","author":"Haldane","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.06.020_bib6","series-title":"Authorizations of Emergency Use of Certain Drug and Biological Products during the COVID-19 Pandemic; Availability","first-page":"10290","year":"2020"},{"key":"10.1016\/j.ymthe.2026.06.020_bib7","series-title":"FDA Takes Additional Action in Fight against COVID-19 by Issuing Emergency Use Authorization for Second COVID-19 Vaccine","year":"2020"},{"key":"10.1016\/j.ymthe.2026.06.020_bib8","series-title":"COVID-19 Deaths","year":"2020"},{"key":"10.1016\/j.ymthe.2026.06.020_bib9","series-title":"The Influenza Imperative: An Urgent Need to Leverage Lessons from COVID-19 to Prepare for a Global Response to Seasonal and Pandemic Influenza","author":"Ballou","year":"2022"},{"key":"10.1016\/j.ymthe.2026.06.020_bib10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s12276-021-00603-0","article-title":"The evolution and future of influenza pandemic preparedness","volume":"53","author":"Harrington","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2026.06.020_bib11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00705-018-3708-y","article-title":"The emerging influenza virus threat: status and new prospects for its therapy and control","volume":"163","author":"Kumar","year":"2018","journal-title":"Arch. Virol."},{"key":"10.1016\/j.ymthe.2026.06.020_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/00333549101250S305","article-title":"Influenza: The Once and Future Pandemic","volume":"125","author":"Taubenberger","year":"2010","journal-title":"Public Health Rep."},{"key":"10.1016\/j.ymthe.2026.06.020_bib13","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2026.06.020_bib14","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.020421","article-title":"Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project","volume":"9","author":"Paget","year":"2019","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.ymthe.2026.06.020_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(18)30496-X","article-title":"Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017","volume":"7","author":"Troeger","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.ymthe.2026.06.020_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103726","article-title":"Analysis of pharma R&D productivity \u2013 a new perspective needed","volume":"28","author":"Schuhmacher","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ymthe.2026.06.020_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.eng.2023.01.014","article-title":"Artificial Intelligence in Pharmaceutical Sciences","volume":"27","author":"Lu","year":"2023","journal-title":"Engineering"},{"key":"10.1016\/j.ymthe.2026.06.020_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.06.020_bib19","series-title":"Harnessing AI to Accelerate Innovation in the Biopharmaceutical Industry","author":"Barbosu","year":"2024"},{"key":"10.1016\/j.ymthe.2026.06.020_bib20","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/d41586-018-05267-x","article-title":"How artificial intelligence is changing drug discovery","volume":"557","author":"Fleming","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.020_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.020_bib22","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","article-title":"De novo design of protein structure and function with RFdiffusion","volume":"620","author":"Watson","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.020_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41586-022-04654-9","article-title":"Design of protein-binding proteins from the target structure alone","volume":"605","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.020_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41586-021-04184-w","article-title":"De novo protein design by deep network hallucination","volume":"600","author":"Anishchenko","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.020_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104300","article-title":"Artificial intelligence in peptide-based drug design","volume":"30","author":"Zhai","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ymthe.2026.06.020_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.06.020_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae275","article-title":"Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides","volume":"25","author":"Goles","year":"2024","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ymthe.2026.06.020_bib28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/ph16030336","article-title":"2022 FDA TIDES (Peptides and Oligonucleotides) Harvest","volume":"16","author":"Al Musaimi","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ymthe.2026.06.020_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/ph17020243","article-title":"2023 FDA TIDES (Peptides and Oligonucleotides) Harvest","volume":"17","author":"Al Shaer","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ymthe.2026.06.020_bib30","article-title":"2020 FDA TIDES (Peptides and Oligonucleotides) Harvest","volume":"14:145","author":"Musaimi","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ymthe.2026.06.020_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/ph13030040","article-title":"2019 FDA TIDES (Peptides and Oligonucleotides) Harvest","volume":"13","author":"Al Shaer","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ymthe.2026.06.020_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/ph12020052","article-title":"2018 FDA Tides Harvest","volume":"12","author":"Al Shaer","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ymthe.2026.06.020_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/ph11020042","article-title":"2017 FDA Peptide Harvest","volume":"11","author":"Al Musaimi","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ymthe.2026.06.020_bib34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/ph15020222","article-title":"2021 FDA TIDES (Peptides and Oligonucleotides) Harvest","volume":"15","author":"Al Shaer","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ymthe.2026.06.020_bib35","article-title":"2024 FDA TIDES (Peptides and Oligonucleotides) Harvest","volume":"18:291","author":"Musaimi","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ymthe.2026.06.020_bib36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/mas.20340","article-title":"PEPTIDE AND PROTEIN DRUGS: THE STUDY OF THEIR METABOLISM AND CATABOLISM BY MASS SPECTROMETRY","volume":"31","author":"Katsila","year":"2012","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.ymthe.2026.06.020_bib37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fchem.2014.00062","article-title":"Current challenges in peptide-based drug discovery","volume":"2","author":"Otvos","year":"2014","journal-title":"Front. Chem."},{"key":"10.1016\/j.ymthe.2026.06.020_bib38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/0194599820933170","article-title":"Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019 (COVID-19): A State of the Art Review","volume":"163","author":"Higgins","year":"2020","journal-title":"Otolaryngol. --head. Neck Surg."},{"key":"10.1016\/j.ymthe.2026.06.020_bib39","article-title":"Computationally Designed Peptides for Zika Virus Detection: An Incremental Construction Approach","volume":"9:498","author":"Mascini","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ymthe.2026.06.020_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113471","article-title":"A new class of sensing elements for sensors: Clamp peptides for Zika virus","volume":"191","author":"Mascini","year":"2021","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.ymthe.2026.06.020_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41586-021-03807-6","article-title":"SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape","volume":"597","author":"Starr","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.020_bib42","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/vaccines11030545","article-title":"Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection","volume":"11","author":"Olukitibi","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2026.06.020_bib43","first-page":"371:6530","article-title":"Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape","author":"Koenig","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.06.020_bib44","article-title":"A broad-spectrum virus-and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.06.020_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.671633","article-title":"Antibodies and Vaccines Target RBD of SARS-CoV-2","volume":"8","author":"Min","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ymthe.2026.06.020_bib46","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.3390\/ijms20246289","article-title":"Peptides, Antibodies, Peptide Antibodies and More","volume":"20","author":"Trier","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.06.020_bib47","doi-asserted-by":"crossref","first-page":"12144","DOI":"10.3390\/ijms241512144","article-title":"Accelerating the Screening of Small Peptide Ligands by Combining Peptide-Protein Docking and Machine Learning","volume":"24","author":"Codina","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.06.020_bib48","doi-asserted-by":"crossref","first-page":"11555","DOI":"10.1128\/JVI.79.18.11555-11558.2005","article-title":"Adaptive Value of High Mutation Rates of RNA Viruses: Separating Causes from Consequences","volume":"79","author":"Elena","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.06.020_bib49","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.molcel.2020.07.027","article-title":"Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting","volume":"79","author":"Robson","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2026.06.020_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ymthe.2026.06.020_bib51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/333426a0","article-title":"Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid","volume":"333","author":"Weis","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.020_bib52","article-title":"Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies","author":"Maurer","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2026.06.020_bib53","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/nprot.2006.202","article-title":"Using circular dichroism spectra to estimate protein secondary structure","volume":"1","author":"Greenfield","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2026.06.020_bib54","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/pro.2443","article-title":"Advantages of proteins being disordered","volume":"23","author":"Liu","year":"2014","journal-title":"Protein Sci."},{"key":"10.1016\/j.ymthe.2026.06.020_bib55","doi-asserted-by":"crossref","first-page":"20545","DOI":"10.1073\/pnas.1312788110","article-title":"Protein recognition and selection through conformational and mutually induced fit","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.06.020_bib56","doi-asserted-by":"crossref","first-page":"13206","DOI":"10.1038\/s41598-020-69995-9","article-title":"Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides","volume":"10","author":"Greco","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.06.020_bib57","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1535370214536679","article-title":"Modeling the lung: Design and development of tissue engineered macro- and micro-physiologic lung models for research use","volume":"239","author":"Nichols","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.ymthe.2026.06.020_bib58","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/term.2113","article-title":"Giving new life to old lungs: methods to produce and assess whole human paediatric bioengineered lungs","volume":"11","author":"Nichols","year":"2017","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.ymthe.2026.06.020_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao3926","article-title":"Production and transplantation of bioengineered lung into a large-animal model","volume":"10","author":"Nichols","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.06.020_bib60","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1152\/physrev.00056.2024","article-title":"Immunological and regenerative properties of lung stem cells","volume":"106","author":"De","year":"2026","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymthe.2026.06.020_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00188-21","article-title":"SARS-CoV-2 Infection and Lung Regeneration","volume":"35","author":"Zhao","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ymthe.2026.06.020_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2026.106204","article-title":"Lack of harmonisation in immunological data: challenges in synthesising data during the COVID-19 pandemic","volume":"126","author":"Shaver","year":"2026","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2026.06.020_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2026.102854","article-title":"Cellular immunotherapy for COVID-19-induced acute respiratory distress syndrome: Results of the CIRCA-19 phase 1 safety and phase 2 randomized controlled trials","volume":"21","author":"English","year":"2026","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2026.06.020_bib64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.020_bib71","author":"Codina"},{"key":"10.1016\/j.ymthe.2026.06.020_bib72","author":"Osorio"},{"key":"10.1016\/j.ymthe.2026.06.020_bib73","author":"Kuhn"},{"key":"10.1016\/j.ymthe.2026.06.020_bib74","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.020_bib75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/pro.4153","article-title":"DichroWeb, a website for calculating protein secondary structure from circular dichroism spectroscopic data","volume":"31","author":"Miles","year":"2022","journal-title":"Protein Sci."},{"key":"10.1016\/j.ymthe.2026.06.020_bib76","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/abio.1993.1079","article-title":"A self-consistent method for the analysis of protein secondary structure from circular dichroism","volume":"209","author":"Sreerama","year":"1993","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymthe.2026.06.020_bib77","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2020.06.021","article-title":"Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626004971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626004971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:24:10Z","timestamp":1788362650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626004971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1525001626004971"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.06.020","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting emerging respiratory pathogens with clamp peptides: Broad-spectrum inhibition of viral entry in 3D human lung models","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}